Multivitamin Injection

The multivitamin injection is indicated in the prevention and treatment of vitamin deficiencies in animals, e.g. growth disturbances, weakness of new‑born animals, convalescense, neonatal anemia, sight disturbances, intestinal trouble, anorexia, not‑infectious reproductive disturbances, rachitis, muscle weakness, muscular tremor and myocardial failure with difficulties in breathing and worm‑infections.

Dosage and Administration:

For subcutaneous or intramuscular injection.

Cattle, horses: 10 ‑ 15 ml per animal.

Swine: 2 – 10 ml per animal.

Calves, foals, goat, sheep: 5 ‑ 10 ml per animal.

Lambs: 5 ‑ 8 ml per animal.

Piglets (10kg): 1 ml per animal.

Piglets (10‑30 kg): 1 ‑ 3 ml per animal.

Storage:  Keep closed in a cool and dry place, away from sunlight and safe from children.

Packing:

Description

Description:

For the prevention and treatment of vitamin deficiencies in animals particularly during periods of illness, convalescence, and general unthriftiness.

Active Ingredients
Vitamin A 15 000 IU
Vitamin D3 25 mg
Vitamin E 20 mg
Vitamin B2, riboflavine sodium phosphate 5 mg
Vitamin B6 3 mg
Nicotinamide 35 mg
Pantothenol 25 mg
Vitamin B12 25 mg
Chlorocresol 1 mg
Parasites, Vectors & Organisms Controlled
Vitamin deficiencies
Indications:

Multivite is indicated for the prevention and treatment of vitamin deficiencies in animals, particularly during periods of illness, convalescence, and general unthriftiness.

Contra-Indications:

None

Application Rate

Cattle Application:

For intramuscular or subcutaneous injection.

Dose rates/directions for use:
Cattle: 20-30 ml
Calves: 5-10 ml

The injection may be repeated at intervals of 10-14 days.

Sheep & Goats Application:

For intramuscular or subcutaneous injection.

Dose rates/directions for use:
Sheep: 5-10 ml
Lambs: 2-5ml
Goats: 5-10 ml

Precautions

Exceeding the highest recommended dosage level of drug per lb of body weight per day, administering more than the recommended number of treatments, and/or exceeding 10 mL intramuscularly or subcutaneously per injection site in adult beef and dairy cattle, and 5 mL intramuscularly per injection site in adult swine, may result in antibiotic residues beyond the withdrawal period.

Consult your veterinarian prior to administering this product in order to determine the proper treatment required in the event of an adverse reaction. At the first sign of any adverse reaction, discontinue the use of the product and seek the advice of your veterinarian. Some of the reactions may be attributed either to anaphylaxis (an allergic reaction) or to the cardiovascular collapse of an unknown cause.

Shortly after injection, treated animals may have transient hemoglobinuria resulting in darkened urine.

As with all antibiotic preparations, the use of this drug may result in the overgrowth of nonsusceptible organisms, including fungi. A lack of response by the treated animal, or the development of new signs, may suggest that an overgrowth of nonsusceptible organisms has occurred. If any of these conditions occur, consult your veterinarian.